Product Information
PHOSPHA 250 NEUTRAL TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.3144 per EA under NDC 64980010401. Its NADAC has been published 660 times since Nov 28, 2013.
PHOSPHA 250 NEUTRAL TABLET
Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium PhosphateStrength
155; 852; 130 mg/1; mg/1; mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980010401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
POTASSIUM PHOSPHATE, MONOBASIC; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEApproval Type
Unapproved
On Market Since
6/28/2012
Price Statistics
The NADAC for PHOSPHA 250 NEUTRAL TABLET has been published 660 times since Nov 28, 2013, and over the history we have for it it has risen 123.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3144 per EA |
|---|---|
| All-time high | $0.3857 (Mar 16, 2016) |
| All-time low | $0.1406 (Nov 28, 2013) |
| 52-week high | $0.3144 |
| 52-week low | $0.1897 |
| Median price | $0.2469 |
| Average price | $0.2558 |
| Largest weekly change | +59.1% (Jan 22, 2014) |
| Weeks tracked | 660 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PHOSPHA 250 NEUTRAL TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHOSPHA 250 NEUTRAL TABLET, manufactured by Rising Pharma Holdings Inc., is $0.3144 per EA (NDC 64980010401), effective Aug 19, 2026.
How has the price of PHOSPHA 250 NEUTRAL TABLET changed over time?
Over the history we have for it, the NADAC for PHOSPHA 250 NEUTRAL TABLET has risen 123.5%. It has been tracked across 660 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PHOSPHA 250 NEUTRAL TABLET?
Since Nov 28, 2013, the NADAC for PHOSPHA 250 NEUTRAL TABLET has ranged from a low of $0.1406 (Nov 28, 2013) to a high of $0.3857 (Mar 16, 2016), with a median of $0.2469 per EA.
Are there cheaper alternatives to PHOSPHA 250 NEUTRAL TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PHOSPHA 250 NEUTRAL TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PHOSPHA 250 NEUTRAL TABLET?
PHOSPHA 250 NEUTRAL TABLET (NDC 64980010401) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.